Claims for Patent: 4,464,468

Summary for Patent: 4,464,468

Title:	Immobilization of active protein by cross-linking to inactive protein
Abstract:	A solution of an active protein substance and an inactive protein substance is reacted with a cross-linking agent, optionally in the presence of an inert carrier, under cross-linking conditions to produce articles comprising both active and inactive protein substances. The active protein substance comprises up to about 20 percent, e.g. from 1 to 20 percent by weight, based on the final weight of the total protein substance, whereas the cross-linking agent comprises from 0.5 to 8 percent by weight, based on the weight of the total treated mixture. The obtained articles are in the form of a solution or a suspension in aqueous medium, in the form of a film, in the form of a membrane, in the form of a fabric, in the form of a porous material, or in the form of a mass, such as granules, pills or tablets.
Inventor(s):	Avrameas; Stratis (La Celle Saint Cloud, FR), Broun; Georges (Rouen, FR), Selegny; Eric (Rouen, FR), Thomas; Daniel (Rouen, FR)
Assignee:	Agence Nationale de Valorisation de la Recherche (ANVAR) (Neuilly-sur-Seine, FR)
Application Number:	06/369,253
Patent Claims:	1. A Self-supporting open-cell foam or sponge consisting essentially of a homogenous distribution of active protein and inactive protein cross-linked together with glutaraldehyde having the following properties: (a) surface area--10.sup.3 cm.sup.2 /cm.sup.3 or, when dry, 1 m.sup.2 /g; (b) specific gravity--0.1 when dry (including open cells); (c) free volume--90 percent; (d) open cell sizes--from 1 to 200 microns; (e) capacity for water absorption--10 times its volume when starting with dry material; (f) absorption capacity--30 percent when considering only the insoluble phase; (g) elasticity (tension modulus)--0.4 to 0.7 kg/mm.sup.2 ; (h) compression--0.2 to 0.9 kg/mm.sup.2, said active protein comprising up to 20 percent by weight of the total active and inactive proteins. 2. A process for producing an immobilized active protein in the form of a self-supporting flexible sheet or film or a self-supporting open-cell foam or sponge consisting essentially of mixing (a) active protein and (b) inactive protein simultaneously with (c) glutaraldehyde in a solvent-containing reaction medium to form a reaction mixture and reacting with active and inactive proteins with said glutaraldehyde under cross-linking conditions until the active protein is cross-linked with the inactive protein through bridges provided by the glutaraldehyde to form said sheet, film, foam or sponge, said active protein comprising up to 20 percent by weight of total active and inactive proteinic substance and said glutaraldehyde being in the range of from 0.5 to 8 percent by weight, based on the weight of total reaction mixture, said sheet or film being formed by spreading said reaction mixture on a surface before cross-linking and said foam or sponge being formed by freezing and slowly thawing said reaction mixture during said cross-linking. 3. A process according to claim 2 wherein cross-linking is effected while reducing the amount of solvent in the reaction medium to form said sheet or film. 4. A process according to claim 2 wherein said foam or sponge is formed. 5. A process according to claim 2 wherein the inactive protein is an albumin and the amount of solvent in the reaction medium is reduced during cross-linking. 6. A process according to claim 2 wherein said sheet or film is formed, the inactive protein is gelatin and the amount of solvent in the reaction medium is reduced during cross-linking. 7. An immobilized active protein produced by the process of claim 2. 8. Immobilized active protein according to claim 7 wherein the active protein is a member selected from the group consisting of antigen, allergen, antibody, hormone, enzyme and proteinic part of a virus or of a cell. 9. Immobilized active protein according to claim 7 wherein the active protein is a member selected from the group consisting of oxidase, hydroxylase, isomerase, transferase, lyase and oxidoreductase. 10. Immobilized active protein according to claim 7 wherein the active protein is a member selected from the group consisting of pepsin, subtilisin, trypsin, chymotrypsin and papain. 11. Immobilized active protein according to claim 7 wherein the active protein is a member selected from the group consisting of glucose-oxidase, carbonic anhydrase, lipolytic hydrolase, amylolytic hydrolase, urease, asparaginase, uricase, peroxidase, catalase, phenylalanine-hydroxylase, galactose phosphate uridyl transferase, pronase, collagenase, keratinase, elastase, urate oxidase, tyrosine decarboxylase, hexokinase, phosphatase, L-amino-acid-oxidase, xanthine oxidase, decarboxylase, ribonuclease, .alpha.-amylase and .beta.-galactosidase. 12. Immobilized active protein according to claim 7 wherein the active protein substantially retains both its activity and specificity. 13. Immobilized active protein according to claim 7 wherein the inactive protein is a member selected from the group consisting of albumin, plasma protein, ovalbumin, fibrinogen, gelatin and hemoglobin. 14. Immobilized active protein according to claim 7 wherein the inactive protein is that found in microbes. 15. Immobilized active protein according to claim 7 wherein the inactive protein is albumin. 16. Immobilized active protein according to claim 8 wherein the inactive protein is a member selected from the group consisting of albumin, plasma protein, ovalbumin, fibrinogen, gelatin, hemoglobin and inactive protein found in microbes. 17. Immobilized active protein according to claim 9 wherein the inactive protein is a member selected from the group consisting of albumin, plasma protein, ovalbumin, fibrinogen, gelatin, hemoglobin and inactive protein found in microbes. 18. Immobilized active protein according to claim 10 wherein the inactive protein is a member selected from the group consisting of albumin, plasma protein, ovalbumin fibrinogen, gelatin, hemoglobin and inactive protein found in microbes. 19. Immobilized active protein according to claim 11 wherein the inactive protein is a member selected from the group consisting of albumin, plasma protein, ovalbumin, fibrinogen, gelatin, hemoglobin and inactive protein found in microbes. 20. Immobilized active protein according to claim 7 wherein the inactive protein is gelatin. 21. Immobilized active protein according to claim 7 wherein the active protein is an antigen. 22. Immobilized active protein according to claim 7 wherein the active protein is an antibody. 23. Immobilized active protein according to claim 7 wherein the active protein is an allergen. 24. Immobilized active protein according to claim 7 wherein the active protein is a part of a virus. 25. Immobilized active protein according to claim 12 wherein the inactive protein is that of a microbe. 26. Immobilized active protein according to claim 7 wherein the active protein and the inactive protein are derived from a single impure source. 27. Immobilized active protein according to claim 26 wherein the single impure source is a microbe source. 28. A flexible sheet or film of immobilized active protein according to claim 1 which is free from a separate or distinct carrier. 29. A sheet or film of immobilized active protein according to claim 7 in combination with an inert non-proteinic carrier which imparts form and strength thereto. 30. A sheet or film of immobilized active protein according to claim 29 wherein the carrier is of a material selected from the group consisting of cellulose, regenerated cellulose, amylose, an alginate, a polysilane, polyvinyl alcohol, aminated paper, a polyacrylamide, silicone sheet, activated carbon and silk. 31. Immobilized active protein according to claim 7 in the form of an open-cell foam or sponge. 32. Immobilized active protein according to claim 7 wherein the active protein is hydrolytic enzyme. 33. Immobilized active protein according to claim 7 wherein the active protein is proteolytic hydrolase. 34. Immobilized active protein according to claim 8 wherein the active protein substantially retains both its activity and specificity and the inactive protein is a member selected from the group consisting of albumin, plasma protein, ovalbumin, fibrinogen, gelatin and hemoglobin.

Details for Patent 4,464,468

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2001-08-07
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2001-08-07